QuantumPharm Inc. (HKG: 2228)

Market Cap	13.90B
Revenue (ttm)	211.77M
Net Income (ttm)	-2.73B
Shares Out	3.41B
EPS (ttm)	-4.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,581,000
Open	4.150
Previous Close	4.040
Day's Range	3.900 - 4.220
52-Week Range	3.510 - 16.200
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About QuantumPharm

QuantumPharm Inc., an investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan. The company’s drug discovery solutions cover the whole drug discovery and research process, including target validation, hit identification, lead generation, lead optimization, and PCC nomination covering various modalities, which comprise small molecules, antibodies, peptides, ADC, and PROTAC. Its intelligent automation solutions focus on AI- and automation-enabled novel dru...

• Industry: Other
• Founded: 2015
• Employees: 783
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2228

Financial Performance

In 2023, QuantumPharm's revenue was 174.42 million, an increase of 30.80% compared to the previous year's 133.35 million. Losses were -1.91 billion, 33.1% more than in 2022.

Financial numbers in CNY